NEWS & EVENTS

Jun 08, 2021

Onward Therapeutics Signs an Exclusive Collaboration and Worldwide Option and License Agreement with Institut du Cancer de Montpellier

 

Read More...

May 04, 2021

Onward Therapeutics SA opened a wholly owned affiliate, Onward Therapeutics France SAS in Paris, France

 

Read More...

Feb 17, 2021

Onward Therapeutics Makes a Strategic Investment in EMERCell for Their NK Cell Technology for Immunotherapy

 

Read More...

Feb 16, 2021

Onward Therapeutics and Biomunex Pharmaceuticals Enter into a Worldwide Exclusive License and Co-development Agreement to a Bispecific Antibody for Immuno-Oncology

 

Read More...